BR9914453A - Cristal de tetrafosfato de diuridina ou seu sal, método de sua preparação e método de produção do mencionado composto - Google Patents

Cristal de tetrafosfato de diuridina ou seu sal, método de sua preparação e método de produção do mencionado composto

Info

Publication number
BR9914453A
BR9914453A BR9914453-0A BR9914453A BR9914453A BR 9914453 A BR9914453 A BR 9914453A BR 9914453 A BR9914453 A BR 9914453A BR 9914453 A BR9914453 A BR 9914453A
Authority
BR
Brazil
Prior art keywords
ump
salts
preparation
salt
ppi
Prior art date
Application number
BR9914453-0A
Other languages
English (en)
Inventor
Hideaki Maeda
Toshio Yamada
Hiroshi Sato
Yutaka Noda
Original Assignee
Yamasa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamasa Corp filed Critical Yamasa Corp
Priority to BRPI9917911A priority Critical patent/BRPI9917911B1/pt
Publication of BR9914453A publication Critical patent/BR9914453A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals
    • C07H19/10Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/10Expectorants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives
    • C07H1/06Separation; Purification
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/02Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with ribosyl as saccharide radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Patente de Invenção <B>"CRISTAL DE TETRAFOSFATO DE DIURIDINA OU SEU SAL, MéTODO DE SUA PREPARAçãO E MéTODO DE PRODUçãO DO MENCIONADO COMPOSTO"<D>, caracterizado pelo fato de que, a presente invenção proporciona cristais de 5' -tetrafosfato de P^ 1^, P^ 4^-di (uridina) ou um de seus sais; um processo de produção dos cristais; e um processo de produção de 5' -tetrafosfato de P^ 1^, P^ 4^-di (uridina) (U~ 2~P~ 4~) ou um de seus sais a partir de UMP, que serve de matéria-prima, e através da utilização de DPC e PPi, com o processo compreendendo pelo menos uma das etapas de tratamento a seguir: (a) adição de UMP e fosfato de difenila (UMP-DPP) em porções divididas durante uma etapa de reação de UMP-DPP com um sal álcali orgânico de PPi; (b) condução da reação de UMP-DPP com um sal álcali orgânico de PPi na presença de uma base; e (c) tratamento adicional do U~ 2~P~ 4~ sintetizado com um álcali. Os cristais de U~ 2~P~ 4~ ou um de seus sais obtidos através do processo de acordo com a presente invenção possuem alta pureza e estabilidade e menor higroscopicidade em comparação com um produto liofilizado, de forma a servir de matéria-prima útil para a preparação de um produto farmacêutico. O processo de produção de U~ 2~P~ 4~ ou um de seus sais de acordo com a presente invenção atinge alto rendimento e permite a síntese em larga escala.
BR9914453-0A 1998-10-02 1999-10-01 Cristal de tetrafosfato de diuridina ou seu sal, método de sua preparação e método de produção do mencionado composto BR9914453A (pt)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BRPI9917911A BRPI9917911B1 (pt) 1998-10-02 1999-10-01 processo de produção de 5'-tetrafosfato de p1,p4 - di(uridina) ou um de seus sais

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP28166398 1998-10-02
JP17068199 1999-06-17
PCT/JP1999/005415 WO2000020430A1 (fr) 1998-10-02 1999-10-01 Cristal de diuridine tetraphosphate ou sel correspondant et procede de fabrication

Publications (1)

Publication Number Publication Date
BR9914453A true BR9914453A (pt) 2001-05-22

Family

ID=26493605

Family Applications (2)

Application Number Title Priority Date Filing Date
BR9914453-0A BR9914453A (pt) 1998-10-02 1999-10-01 Cristal de tetrafosfato de diuridina ou seu sal, método de sua preparação e método de produção do mencionado composto
BRPI9917911A BRPI9917911B1 (pt) 1998-10-02 1999-10-01 processo de produção de 5'-tetrafosfato de p1,p4 - di(uridina) ou um de seus sais

Family Applications After (1)

Application Number Title Priority Date Filing Date
BRPI9917911A BRPI9917911B1 (pt) 1998-10-02 1999-10-01 processo de produção de 5'-tetrafosfato de p1,p4 - di(uridina) ou um de seus sais

Country Status (21)

Country Link
US (2) US6458946B1 (pt)
EP (1) EP1043329B1 (pt)
JP (2) JP3247685B2 (pt)
KR (1) KR100475008B1 (pt)
CN (2) CN100396692C (pt)
AT (1) ATE222920T1 (pt)
AU (1) AU747096C (pt)
BR (2) BR9914453A (pt)
CA (1) CA2345624C (pt)
CZ (1) CZ300402B6 (pt)
DE (1) DE69902624T2 (pt)
EA (2) EA004513B1 (pt)
ES (1) ES2183650T3 (pt)
HU (1) HU228681B1 (pt)
IL (1) IL142181A (pt)
MX (1) MXPA01003377A (pt)
NO (1) NO317305B1 (pt)
NZ (1) NZ510748A (pt)
PL (1) PL199434B1 (pt)
SK (1) SK283729B6 (pt)
WO (1) WO2000020430A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7078391B2 (en) * 1997-02-10 2006-07-18 Inspire Pharmaceuticals, Inc. Method of treating edematous retinal disorders
US6818629B2 (en) 1997-02-10 2004-11-16 Inspire Pharmaceuticals, Inc. Pharmaceutical formulation comprising P1-(2'-deoxycytidine 5'-)P4-(uridine 5'-) tetraphosphate
US7223744B2 (en) 1997-02-10 2007-05-29 Inspire Pharmaceuticals, Inc. Pharmaceutical formulation comprising dinucleoside polyphosphates and salts thereof
US6872710B2 (en) 1997-07-25 2005-03-29 Inspire Pharmaceuticals, Inc. Di(uridine 5′)-tetraphosphate and salts thereof
PL202176B1 (pl) * 1999-06-30 2009-06-30 Yamasa Corp Sposób wytwarzania P¹-(2'-deoksycytydyno-5')-P⁴-(urydyno-5')czterofosforanu
US6867199B2 (en) 2000-08-21 2005-03-15 Inspire Pharmaceuticals, Inc. Dinucleoside polyphosphate compositions and their therapeutic use
CN100363376C (zh) * 2006-06-12 2008-01-23 南京工业大学 一种5’-核苷三磷酸钠盐的结晶方法
JPWO2017002827A1 (ja) * 2015-06-29 2018-04-26 ヤマサ醤油株式会社 P1,p4−ビス(5’−ウリジル)テトラホスフェート結晶の保管方法
US10815263B2 (en) 2016-10-25 2020-10-27 Yamasa Corporation Method for purifying P1,P4-di(uridine 5′-)tetraphosphate
KR20180091689A (ko) 2017-11-06 2018-08-16 주식회사 종근당 무정형 디뉴클레오사이드 폴리포스페이트 화합물의 제조방법
CN109021049B (zh) * 2018-06-14 2020-12-08 扬子江药业集团北京海燕药业有限公司 一种尿苷5′-二磷酸-苯并咪唑二钠的合成方法
KR20210110055A (ko) * 2020-02-28 2021-09-07 주식회사 종근당바이오 P1, p4-디(우리딘 5'-)테트라포스페이트 나트륨염 4 수화물 결정형 a의 제조방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6423694B1 (en) * 1996-02-21 2002-07-23 Inspire Pharmaceuticals, Inc. Method of treating otitis media with uridine triphosphates and related compounds
DE69736468T2 (de) * 1996-03-27 2007-03-29 Inspire Pharmaceuticals, Inc. Verfahren zur behandlung der ziliardyskinesie mit uridintriphosphaten und verwandten verbindungen
US6319908B1 (en) * 1996-07-03 2001-11-20 Inspire Pharmaceuticals, Inc. Method for large-scale production of di(uridine 5′-tetraphosphate) and salts thereof
US5763447C1 (en) * 1996-07-23 2002-05-07 Inspire Pharmaceuticals Method of preventing or treating pneumonia in immobilized patients with uridine triphosphates and related compounds
BRPI9810436B1 (pt) * 1997-07-25 2015-12-29 Inspire Pharmaceuticals Inc processo para a produção em larga escala de di (5'-tetrafosfato de uridina) e sais do mesmo

Also Published As

Publication number Publication date
EA004513B1 (ru) 2004-04-29
JP3247685B2 (ja) 2002-01-21
HU228681B1 (en) 2013-05-28
US6780988B2 (en) 2004-08-24
JP3824894B2 (ja) 2006-09-20
CA2345624C (en) 2006-12-05
PL347070A1 (en) 2002-03-11
SK283729B6 (sk) 2003-12-02
CN1321163A (zh) 2001-11-07
CZ300402B6 (cs) 2009-05-13
NO20011634L (no) 2001-05-30
US6458946B1 (en) 2002-10-01
NO20011634D0 (no) 2001-03-30
HUP0103754A2 (hu) 2002-04-29
DE69902624D1 (de) 2002-10-02
MXPA01003377A (es) 2003-06-24
IL142181A0 (en) 2002-03-10
US20020156269A1 (en) 2002-10-24
EA003167B1 (ru) 2003-02-27
CN1502622A (zh) 2004-06-09
CZ20011028A3 (cs) 2001-08-15
AU747096B2 (en) 2002-05-09
ATE222920T1 (de) 2002-09-15
BRPI9917911B1 (pt) 2016-08-23
IL142181A (en) 2005-12-18
WO2000020430A1 (fr) 2000-04-13
KR20020013471A (ko) 2002-02-20
EP1043329A4 (en) 2001-03-14
NO317305B1 (no) 2004-10-04
ES2183650T3 (es) 2003-03-16
NZ510748A (en) 2002-10-25
EP1043329B1 (en) 2002-08-28
EP1043329A1 (en) 2000-10-11
SK4402001A3 (en) 2001-11-06
DE69902624T2 (de) 2003-04-03
JP2002053590A (ja) 2002-02-19
KR100475008B1 (ko) 2005-03-08
EA200200695A1 (ru) 2002-10-31
CN1151166C (zh) 2004-05-26
CA2345624A1 (en) 2000-04-13
AU747096C (en) 2003-01-23
CN100396692C (zh) 2008-06-25
EA200100407A1 (ru) 2001-10-22
AU6000899A (en) 2000-04-26
HUP0103754A3 (en) 2003-01-28
PL199434B1 (pl) 2008-09-30

Similar Documents

Publication Publication Date Title
BR9914453A (pt) Cristal de tetrafosfato de diuridina ou seu sal, método de sua preparação e método de produção do mencionado composto
DE69012840T2 (de) Adenosin-Derivate, die eine Aktivität gegen Bluthochdruck haben.
BR9915985A (pt) 2-cianopirrolidinas n-substituìdas
KR910007950A (ko) 결정질 2-O-α-D-글루코피라노실-L-아스코르브산, 그 제조방법 및 용도
JPH01287069A (ja) メルカプトアシルプロリン誘導体の製法ならびに用途
ES2054501T3 (es) Procedimiento para la fabricacion de ramnosa a partir de ramnolipidos.
US4895873A (en) Calcium salt of valproic acid
BR0011708A (pt) Derivados de indol e seu uso para o tratamento de osteoporose dentre outras aplicações
BR9807392A (pt) Processo para produzir um produto clivado a partir de um composto ricìnico por uma reação de oxidação cáustica em alta temperatura, e, mistura de reação para produzir um produto clivado a partir de óleo de rìcino ou seus derivados por oxidação em alta temperatura.
US5990098A (en) Therapeutic use of 1-amino-3-(N,N-dimethylamino)-propylidene-1,1-bisphosphonic acid and its salts
BR0012205A (pt) Cristais de dinucleótido
DE69108408T2 (de) 4,5-dihydroxy und 4,5,8-trihydroxy-9,10-dioxo-2-anthracencarbonsäure-dikohlensäureester und urethane mit therapeutischer wirkung.
Fuentes et al. An easy route to seven-membered iminocyclitols from aldohexopyranosyl enamines
CN112538099A (zh) 一种全酰基保护的1-硫代葡萄糖、葡萄糖1-硫醇的制备方法及其应用
ES2010972T3 (es) Metodo para la preparacion de lactulosa cristalina de alta pureza y el producto obtenido.
US4939164A (en) Strontium salt
DE69624235T2 (de) Derivate der epoxybernsteinsäure
Eckstein et al. Stereochemistry of the transesterification step of pancreatic ribonuclease
US5679645A (en) Sialic acid powder and process for the preparation thereof
US3842107A (en) Phosphine or phosphite gold complexes of thiobenzoic acid and substituted thiophenols
US4515782A (en) Substituted phenyl-1-thio(poly-O-sulfo)-α(or β)-D-glucopyranosides
BR9708963A (pt) Processo para a preparação de ivermectina
CA2159850A1 (en) Phosphonosulfonate squalene synthetase inhibitor salts and method
SU1595837A1 (ru) Способ получени дифенилкарбоната
Yamamoto et al. Synthesis of 1, 2, 4-tri-O-acetyl-5-deoxy-5-[(R, S)-ethyl-and phenylphosphino]-3-O-methyl-. ALPHA.,. BETA.-D-xylopyranoses and an efficient conversion to the corresponding 5-(phosphinothioyl)-D-xylopyranoses.

Legal Events

Date Code Title Description
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) DA LPI

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.